Ignite Creation Date:
2025-12-24 @ 4:35 PM
Ignite Modification Date:
2026-01-29 @ 8:21 PM
Study NCT ID:
NCT02976766
Status:
TERMINATED
Last Update Posted:
2025-12-19
First Post:
2016-11-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Gypenosides Treatment for Optic Neuritis
Sponsor:
First Affiliated Hospital of Guangxi Medical University
Organization:
Study Overview
Official Title:
Gypenosides Treatment for Optic Neuritis: a Randomised, Double-blind, Placebo-controlled Trial
Status:
TERMINATED
Status Verified Date:
2025-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Low enrolment
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine whether gypenosides are neuroprotective in patients with acute optic neuritis.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: